Literature DB >> 17092279

Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen.

Daniel A Barocas1, Susan Mathew, Joseph J DelPizzo, E Darracott Vaughan, R Ernest Sosa, Ronnie G Fine, Mohamed Akhtar, Douglas S Scherr.   

Abstract

OBJECTIVE: To determine the subtype of renal cell carcinoma (RCC) on needle-core biopsies of renal masses using histopathology and fluorescence in situ hybridization (FISH), and to evaluate the use of interphase FISH to augment the accuracy of needle-core biopsies. PATIENTS AND METHODS: Histology correlates with prognosis in RCC but, historically, biopsies are inaccurate for histological subtype. As histological subtypes of RCC have distinct cytogenetic abnormalities (loss of 3p in clear cell, trisomy 7 or 17 in papillary and widespread chromosomal losses in chromophobe), we hypothesized that FISH would improve the accuracy of biopsies. Forty patients with renal masses underwent nephrectomy, yielding 42 tumours. Needle-core biopsies were taken of the mass immediately after surgery. Interphase FISH was performed on one core for chromosomes 3, 7, 10, 13, 17, and 21 and the locus 3p25-26. Histopathology was performed on a second core. Results were compared in a 'blinded' fashion with final pathology.
RESULTS: In all, 36 of 42 masses were RCC or oncocytoma. Histopathology of the biopsy correctly identified the tumour subtype in 27 (75%), while four (11%) were incorrectly classified and five (14%) were inadequate for diagnosis. With the addition of FISH, 31 (86%) were correctly subtyped, while two (6%) were incorrect and three (8%) were inadequate. In cases with adequate tissue, histology alone was 87% accurate, while the combined method was 94% accurate.
CONCLUSION: Needle-core biopsy of renal tumours provides adequate material for evaluation of histological subtype. Adding FISH to histopathology might improve the accuracy of kidney tumour biopsies, providing important prognostic information that can guide management decisions.

Entities:  

Mesh:

Year:  2006        PMID: 17092279     DOI: 10.1111/j.1464-410X.2006.06607.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  16 in total

1.  The role of percutaneous renal biopsy in the management of small renal masses.

Authors:  Rou Wang; Amy Y Li; David P Wood
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

Review 2.  [Oncocytoma versus chromophobe renal cell carcinoma: Is there something in between?].

Authors:  C Lüders; G Kristiansen
Journal:  Pathologe       Date:  2016-03       Impact factor: 1.011

3.  The impact of location and number of cores on the diagnostic accuracy of renal mass biopsy: an ex vivo study.

Authors:  David J Hobbs; Ming Zhou; Steven C Campbell; Hakan Aydin; Christopher J Weight; Brian R Lane
Journal:  World J Urol       Date:  2012-04-15       Impact factor: 4.226

Review 4.  The role of radiologic imaging and biopsy in renal tumor ablation.

Authors:  Omar Ortiz-Alvarado; James Kyle Anderson
Journal:  World J Urol       Date:  2010-04-24       Impact factor: 4.226

Review 5.  Interpretation of needle biopsies of the kidney for investigation of renal masses.

Authors:  Benoît Lhermitte; Laurence de Leval
Journal:  Virchows Arch       Date:  2012-06-08       Impact factor: 4.064

6.  Microarray gene expression profiling using core biopsies of renal neoplasia.

Authors:  Craig G Rogers; Jonathon A Ditlev; Min-Han Tan; Jun Sugimura; Chao-Nan Qian; Jeff Cooper; Brian Lane; Michael A Jewett; Richard J Kahnoski; Eric J Kort; Bin T Teh
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

7.  Chromophobe renal cell carcinoma: useful diagnostic application of imprint cytology and fluorescence in situ hybridization of chromosomes 10 and 21 in two cases of typical and eosinophilic variants.

Authors:  Naoto Kuroda; Kazunobu Katto; Tadanori Yamaguchi; Takako Kawada; Yoshiaki Imamura; Ondrej Hes; Michal Michal; Taro Shuin; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2008-12-24       Impact factor: 2.309

8.  The importance of histology and cytogenetics in decision making for renal cell carcinoma.

Authors:  Julia G Garcia; Maria M Picken; Robert C Flanigan
Journal:  World J Urol       Date:  2008-04-08       Impact factor: 4.226

Review 9.  The evolving management of small renal masses.

Authors:  Stephen A Boorjian; Robert G Uzzo
Journal:  Curr Oncol Rep       Date:  2009-05       Impact factor: 5.075

10.  Cytogenetic and immunohistochemical study of 42 pigmented microcystic chromophobe renal cell carcinoma (PMChRCC).

Authors:  Francisco Javier Queipo Gutiérrez; Ángel Panizo; Antonio Tienza; Irene Rodriguez; Jesús Javier Sola; Jordi Temprana-Salvador; Inés de Torres; Javier Pardo-Mindán
Journal:  Virchows Arch       Date:  2018-06-21       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.